Agios Pharmaceuticals Inc (AGIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AGIO Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Agios Pharmaceuticals Inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent113.60
Available-for-sale Securities, Debt Securities, Current MA623.44
Cash & Short-term Investments736.00
Inventories35.09
Other Current Assets16.13
Prepaid Expense And Other Assets Current46.59
Total Current Assets834.84
Equipment/Property/Plant Net10.57
Long-term investments308.45
Other Assets, Noncurrent31.13
Operating Lease Right Of Use Asset27.20
Total Assets1,184.99
Liabilities
Accounts Payable, Current AC13.75
Accrued Liabilities, Current AC26.29
Other Liabilities, Current0.00
Taxes Payable, Current, Total0.00
Total Current Liabilities58.85
Total Long-term Debt0.00
Other liabilities, Noncurrent35.84
Operating Lease Liability Current18.81
Total Liabilities75.88
Stockholders' Equity
Common Stock Value0.08
Treasury Stock Value-802.49
Additional Paid In Capital Common Stock2,572.66
Retained Earnings / Accumulated Deficit-660.82
Other Equity-0.31
Common Stockholder's Equity1,109.12
Total Stockholder's Equity1,109.12
Liabilities & Stockholder's Equity1,184.99
4 historic quarters locked

Sign in to unlock the full Agios Pharmaceuticals Inc balance sheet history.

About Agios Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001439222-26-000118

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.